The body fights infection amidst ‘waves’ of regulatory CD4+ T cells
"The immune system has devised this remarkable way to rapidly protect the host from acute inflammation."
Current vaccines teach T cells to fight Omicron
Four COVID-19 vaccines prompt the body to make effective, long-lasting T cells against SARS-CoV-2.
Partial bone marrow transplant ‘rescues’ mice with cystic fibrosis
New bone marrow gives sick mice healthy monocytes
Macrophages in the artery wall ‘smell’ their surroundings
Immune cells can sniff out octanal in blood, triggering dangerous inflammation and atherosclerosis
LJI and Charles River Laboratories to collaborate on COVID-19 research
New agreement paves the way for better mouse models to study how the human immune system fights SARS-CoV-2
Strange DNA structures may drive cancer development
LJI researchers shed light on the role of TET enzymes in genomic stability and cancers
Once upon a BCG vaccine
LA JOLLA—A long, long time ago, the BCG vaccine was approved for use against tuberculosis (TB), and it’s still
New vaccine ingredient shows promise
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
Suffering from psoriasis? Blame this trio of proteins
LA JOLLA—About 7.5 million Americans suffer from psoriasis, an autoimmune disease that shows up as patches of red, inflamed
COVID-19 case severity: How genetic differences leave immune cells at a disadvantage
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
LJI graduate students win prestigious ARCS San Diego awards
ARCS support propels vaccine design and HIV research
Erica Ollmann Saphire receives $2.6 million grant to collaborate on pan-coronavirus vaccine
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family